Navigation Links
Hoyos Corporation Rolls Out First Iris-Biometrics System Priced to Compete with Generic Card Readers
Date:12/7/2010

NEW YORK, Dec. 7, 2010 /PRNewswire/ -- Hoyos Corporation (Hoyos), a Puerto Rico based advanced R&D laboratory and intellectual property holding company, announced today that they will add a new iris scanning device, called the EyeSwipe-Nano™, to their suite of cutting edge identity management products.

The EyeSwipe-Nano™ will be approximately one quarter of the size of the break-through EyeSwipe-Mini®, roughly the footprint of a dollar bill. The new product can capture the irises of people from a distance and in motion at a rate of twenty people per minute.  The high throughput, accuracy, and ease of use make this device a highly attractive product for commercial, industrial, and high-density residential property usage.

The EyeSwipe-Nano™ will use the same iris-scanning technology that powers Hoyos' entire suite of biometrics products.  The product will be commercially available during the first quarter of 2011 and will be comparably priced to older technology card readers on the market today.  

"Token-based access control systems are the most prevalent form of security in commercial real estate spaces around the world.  The EyeSwipe-Nano™ will provide Pentagon-level security at price levels that any current or prospective user of card access such as property managers, financial institutions, manufacturers, retailers, REIT, or individual building owners can afford," said Hector Hoyos, CEO of Hoyos Corporation.

Hoyos has revolutionized the access control and identity management industry by delivering next-generation iris based systems to companies in the financial services and government sectors.  They anticipate expansion into the consumer sector in 2011.  The Company has developed a portfolio of hardware and software services and business methods that utilize iris biometric technologies to help governments and businesses around the world overcome the everyday challenges of identity management.  Hoyos' current portfolio of proven products includes the HBOX®, HBOX®-V, HCAM®, EyeSwipe®, and EyeSwipe-Mini®.

About Hoyos CorporationHoyos Corporation is a global company with shareholders from across the world. It was incorporated in San Juan, Puerto Rico in November of  2005 as an intellectual property holding company with a world class R&D operation. Today, Hoyos is revolutionizing the access control and identity management industry. The global reliance upon electronic data and transactions has created an increasing need to secure identity and control access to physical locations, electronic networks and the devices that connect to them in order to combat the very costly threats of identity theft and financial fraud. Hoyos delivers a vastly different operating model where privacy, convenience and security are synonymous. Media Contacts:Sharron Silvers / Samantha Wolf KCSA Strategic Communications(212) 896-1282 / (212) 896-1220ssilvers@kcsa.com / swolf@kcsa.com
'/>"/>

SOURCE Hoyos Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related biology news :

1. Communication Intelligence Corporation Reports Third Quarter 2008 Financial Results
2. Communication Intelligence Corporation Reports Fourth Quarter and Fiscal 2008 Results
3. CEL-SCI Corporation to Launch Aseptic Filling for Stem Cell Produced Therapies and Other Biological Products
4. delSECUR CORPORATION Announces Appointment of the Companys President & CEO
5. $29.4 million grant establishes CTSI at NYU in partnership with Health and Hospitals Corporation
6. delSECUR CORPORATION Announces Agreement to Purchase the Intellectual Property Assets of the Corporation
7. delSECUR CORPORATION Announces Agreement to Purchase the Intellectual Property Assets of the Corporation
8. M2SYS Biometric Software Solution Selected By GHG Corporation
9. Harris Corporation Adds Broadband Satellite Data Mode to JTRS-Approved Falcon III(R) AN/PRC-117G Multiband Manpack Radio
10. GenVault Corporation to Present at the 2009 BIOCOM Investor Conference
11. GenVault Corporation to Present at the 2009 BIOCOM Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/12/2016)... May 12, 2016 WearablesResearch.com , a ... the overview results from the Q1 wave of its ... wave was consumers, receptivity to a program where they ... a health insurance company. "We were surprised ... says Michael LaColla , CEO of Troubadour Research, ...
(Date:4/28/2016)... 2016 First quarter 2016:   ... with the first quarter of 2015 The gross margin ... (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) , ... unchanged, SEK 7,000-8,500 M. The operating margin for 2016 ...
(Date:4/15/2016)...  A new partnership announced today will help ... in a fraction of the time it takes ... life insurance policies to consumers without requiring inconvenient ... Diagnostics, rapid testing (A1C, Cotinine and HIV) and ... weight, pulse, BMI, and activity data) available at ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm Sciences, Inc. is ... has received AOAC Research Institute approval 061601. , “This is another AOAC-RI approval ... Bob Salter, Vice President of Regulatory and Industrial Affairs. “The Peel Plate methods ...
(Date:6/23/2016)... --  EpiBiome , a precision microbiome engineering company, today ... from Silicon Valley Bank (SVB). The financing will allow ... drug development efforts, as well as purchase additional lab ... been an incredible strategic partner to us – one ... provide," said Dr. Aeron Tynes Hammack , EpiBiome,s ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... In a ... Hospital in Denmark detail how a patient who developed lymphedema after being treated for ... The results could change the paradigm for dealing with this debilitating, frequent side effect ...
Breaking Biology Technology: